CIK 0001561921 · Non-accelerated filer<br>Smaller reporting company
TELA Bio, Inc.
Sign in to watch- Ticker
- TELA
- Exchange
- Nasdaq
- Industry
- Surgical & Medical Instruments & Apparatus
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 455320061
- Phone
- 484-320-2930
- Business address
- 1 GREAT VALLEY PARKWAY, SUITE 24, MALVERN, PA, 19355
- Open-market buys, last 90 days
- $175,549
- in 3 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Net +$175,549. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-02-21 | Smeykal Megan Chief Accounting Officer | Shares withheld for taxes | −1,590 | $0.72 | $1K | 67,296 |
| 2026-02-21 | Talmo Paul Chief Technology Officer | Shares withheld for taxes | −3,385 | $0.72 | $2K | 177,497 |
| 2026-02-21 | Cuca Roberto COO and CFO | Shares withheld for taxes | −4,780 | $0.72 | $3K | 262,611 |
| 2026-02-21 | KOBLISH ANTONY Chief Executive Officer | Shares withheld for taxes | −12,494 | $0.72 | $9K | 753,616 |
| 2026-02-20 | Blizard Jeffrey President | Grant or award | +86,000 | 205,125 | ||
| 2026-02-20 | Blizard Jeffrey President | Grant or award · Stock Option (Right to Buy) | +127,000 | 127,000 | ||
| 2026-02-20 | Firestone Gregory A. Chief Business Officer | Grant or award | +37,000 | 144,848 | ||
| 2026-02-20 | Firestone Gregory A. Chief Business Officer | Grant or award · Stock Option (Right to Buy) | +55,000 | 55,000 | ||
| 2026-02-20 | Talmo Paul Chief Technology Officer | Grant or award | +57,000 | 180,882 | ||
| 2026-02-20 | Talmo Paul Chief Technology Officer | Grant or award · Stock Option (Right to Buy) | +85,000 | 85,000 | ||
| 2026-02-20 | Cuca Roberto COO and CFO | Grant or award | +57,000 | 267,391 | ||
| 2026-02-20 | Cuca Roberto COO and CFO | Grant or award · Stock Option (Right to Buy) | +85,000 | 85,000 | ||
| 2026-02-20 | KOBLISH ANTONY Chief Executive Officer | Grant or award | +176,000 | 766,110 | ||
| 2026-02-20 | KOBLISH ANTONY Chief Executive Officer | Grant or award · Stock Option (Right to Buy) | +261,000 | 261,000 | ||
| 2026-02-19 | Smeykal Megan Chief Accounting Officer | Shares withheld for taxes | −795 | $0.80 | $632 | 68,886 |
| 2026-02-18 | Smeykal Megan Chief Accounting Officer | Grant or award | +32,850 | 69,681 | ||
| 2025-11-17 | EW HEALTHCARE PARTNERS FUND 2, L.P. 10% owner | Purchase | +3,604,000 | $1.11 | $4.0M | 7,714,709 |
| 2025-10-31 | Plovanic William J. Director | Grant or award | +11,925 | 11,925 | ||
| 2025-10-31 | Plovanic William J. Director | Grant or award · Stock Option (Right to Buy) | +17,550 | 17,550 | ||
| 2025-10-09 | Rocchio Betty Jo Director | Grant or award | +11,925 | 11,925 |
Page 3 of 12 · 237 trades